Achyut Healthcare Reports Strong Revenue Growth Amid Profit Decline in FY26

Achyut Healthcare Limited announced its audited financial results for the fiscal year ending March 31, 2026. The company's revenue from operations reached ₹11.59 crore, a substantial rise from ₹3.05 crore in the prior fiscal year. Despite this strong top-line growth, the net profit for FY26 decreased to ₹0.32 crore, down from ₹0.51 crore in FY25.

Key Financials and Corporate Milestones

The financial year saw Achyut Healthcare achieve a nearly fourfold increase in revenue. This expansion was coupled with a successful migration to the Main Board of BSE Limited, which was completed on January 2, 2026. The company also appointed M/s. Mohta Khetawat & Co. as its internal auditor for the FY26-27 period.

Investor Outlook and Concerns

While the revenue jump signals growing market presence, the dip in profitability raises questions about cost management and margin efficiency. Investors will be keen to understand how the company plans to address the rising costs that impacted its net profit despite higher sales. The migration to the Main Board is a significant step, potentially offering better visibility and access to capital markets, but the focus will likely remain on improving profit margins.

Operational and Financial Context

In the preceding fiscal year (FY25), Achyut Healthcare had reported revenues of ₹3.05 crore and a net profit of ₹0.51 crore. The company operated on the SME Platform before its transition to the Main Board. As of March 31, 2026, the company's total assets stood at ₹38.09 crore. A preferential allotment of 58,00,000 equity shares at ₹6 per share was finalized on March 23, 2026, aimed at bolstering the company's capital base.

Future Focus for Achyut Healthcare

With its enhanced corporate standing on the BSE Main Board, Achyut Healthcare faces increased regulatory scrutiny and investor expectations. The immediate challenge for management will be to demonstrate a clear strategy for managing operational costs and enhancing profitability to complement its revenue growth. Investors will monitor upcoming quarterly results for signs of margin improvement.